Cargando…
Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures
Extended release (XR) formulation of levetiracetam (LEV) is approved by the Food and Drug Administration as an add-on to other antiepileptic drugs (AEDs) for adults with partial onset seizures. This is based on class-I evidence demonstrating significant seizure reduction in once daily dosing. Keppra...
Autores principales: | Sonmezturk, Hasan H., Azar, Nabil J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663601/ https://www.ncbi.nlm.nih.gov/pubmed/23861635 http://dx.doi.org/10.4137/JCNSD.S4126 |
Ejemplares similares
-
Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
por: Ulloa, Carol M, et al.
Publicado: (2009) -
Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
por: Cormier, Justine, et al.
Publicado: (2013) -
Efficacy and Safety of Levetiracetam and Carbamazepine as Monotherapy in Partial Seizures
por: Suresh, Swaroop Hassan, et al.
Publicado: (2015) -
Role of Levetiracetam in Neonatal Seizure
por: Murty, Yerramilli V.S.S., et al.
Publicado: (2012) -
Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial
por: French, JA, et al.
Publicado: (2014)